✦ LIBER ✦

Bacillus calmette—Guérin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder. Four-year results

✍ Scribed by Hideyuki Akaza; Shiro Hinotsu; Yoshio Aso; Tadao Kakizoe; Bladder Cancer BCG Study Group

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 704 KB
Volume: 75
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19950115)75:2<552::aid-cncr2820750219>3.0.co;2-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of intravesical bacillus calmette

Effect of intravesical bacillus calmette-guerin (BCG) on carcinoma in situ of the bladder

✍ Harry W. Herr; Carl M. Pinsky; Willet F. Whitmore Jr.; Herbert F. Oettgen; Myron 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 1 views

Effects of bacillus Calmette-Guérin and

Effects of bacillus Calmette-Guérin and interferon-α-2B on human bladder cancer in vitro

✍ Ye Zhang; Hoon Eng Khoo; Kesavan Esuvaranathan 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 160 KB

The cytolytic and anti-proliferative effects of bacillus Calmette-Gue ´rin (BCG) and/or interferon-a-2b (IFN-a-2b) on 5 human bladder carcinoma cell lines, RT4, RT112, MGH, SD and J82, were determined. The cell lines showed different sensitivities to BCG and IFN-a-2b. BCG had direct dosedependent cy

The prognostic value of cytology and flu

The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy

✍ Spasenija Savic; Inti Zlobec; George N. Thalmann; Daniel Engeler; Martina Schmau 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 169 KB

## Abstract Molecular markers reliably predicting failure or success of Bacillus Calmette‐Guérin (BCG) in the treatment of nonmuscle‐invasive urothelial bladder cancer (NMIBC) are lacking. The aim of our study was to evaluate the value of cytology and chromosomal aberrations detected by fluorescenc

Prospective phase II trial of alternatin

Prospective phase II trial of alternating intravesical Bacillus Calmette-Guérin (BCG) and Interferon alpha IIB in the treatment and prevention of superficial transitional cell carcinoma of the urinary bladder: Preliminary results

✍ S. Bazarbashi; M.A. Raja; A. El Sayed; A. Ezzat; E. Ibrahim; S. Kattan; A. Karda 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

IL-17 production by γδ T cells is import

IL-17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guérin treatment against bladder cancer

✍ Ario Takeuchi; Takashi Dejima; Hisakata Yamada; Kensuke Shibata; Risa Nakamura; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB

Adjuvant immunotherapy treatment of rena

Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and Bacillus Calmette-Guèrin: Five-year results of a prospective randomized study

✍ Enzo Galligioni; Michele Quaia; Alberto Merlo; Antonino Carbone; Antonella Spada 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

## BACKGROUND. Active specific immunotherapy (ASI) is a strategy that attempts to boost the host's immune response specifically against its own tumor. The purpose of this study was to investigate the effect of adjuvant AS1 in patients with renal carcinoma. ## METHODS. Of 120 consecutive patient